118 related articles for article (PubMed ID: 7510817)
1. Filgrastim combined with tretinoin in acute promyelocytic leukaemia.
Usuki K; Ikeda Y; Kitazume K; Iwabe K; Okuyama Y; Urabe A
Lancet; 1994 Mar; 343(8900):803-4. PubMed ID: 7510817
[No Abstract] [Full Text] [Related]
2. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin.
Lin CP; Huang MJ; Liu HJ; Chang IY; Tsai CH
Am J Hematol; 1996 Mar; 51(3):251-2. PubMed ID: 8619417
[No Abstract] [Full Text] [Related]
3. Acute promyelocytic leukaemia, tretinoin, and granulocyte colony-stimulating factor.
Nakajima K; Hatake K; Miyata T; Muroi K; Komatsu N; Miura Y
Lancet; 1994 Jan; 343(8890):173-4. PubMed ID: 7506343
[No Abstract] [Full Text] [Related]
4. Probable in vivo induction of differentiation by recombinant human granulocyte colony stimulating factor (rhG-CSF) in acute promyelocytic leukaemia (APL).
Yamasaki Y; Izumi Y; Sawada H; Fujita K
Br J Haematol; 1991 Aug; 78(4):579-80. PubMed ID: 1716958
[No Abstract] [Full Text] [Related]
5. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia pretreated with filgrastim mimicking acute promyelocytic leukemia.
Bartlett JR; Lunde JH
Blood; 2014 Jun; 123(25):3853. PubMed ID: 25083521
[No Abstract] [Full Text] [Related]
7. [Complete remission induced by combined treatment with all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in a patient with relapsed acute promyelocytic leukemia].
Wakayama T; Furuya H; Takagi C; Ichiba S; Kato Y
Rinsho Ketsueki; 1994 Nov; 35(11):1315-21. PubMed ID: 7529843
[TBL] [Abstract][Full Text] [Related]
8. The combined effects of all-trans retinoic acid and granulocyte colony-stimulating factor as a differentiation induction therapy for acute promyelocytic leukemia.
Tsurumi H; Tojo A; Takahashi T; Moriwaki H; Asano S; Muto Y
Intern Med; 1993 Aug; 32(8):648-50. PubMed ID: 7508772
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of tretinoin in acute promyelocytic leukaemia.
Schmitt K; Schwarz R; Tulzer G; Krieger O; Zoubek A; Gadner H
Lancet; 1994 Feb; 343(8893):361. PubMed ID: 7905174
[No Abstract] [Full Text] [Related]
10. [Treatment of acute myelogenous leukemia].
Ono R
Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1040-5. PubMed ID: 1383364
[No Abstract] [Full Text] [Related]
11. Tretinoin toxicity in children with acute promyelocytic leukaemia.
Mahmoud HH; Hurwitz CA; Roberts WM; Santana VM; Ribeiro RC; Krance RA
Lancet; 1993 Dec; 342(8884):1394-5. PubMed ID: 7901684
[TBL] [Abstract][Full Text] [Related]
12. Cytokines and retinoic acid therapy for APL: new tricks from an old combination.
Witcher M; Miller WH
Leuk Res; 2004 May; 28(5):447-8. PubMed ID: 15068896
[No Abstract] [Full Text] [Related]
13. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
14. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
Zver S; Andoljsek D; Cernelc P
Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
[No Abstract] [Full Text] [Related]
16. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
Hamidah HN; Cheong SK; Ainoon O
Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of tretinoin in acute promyelocytic leukaemia.
Yokokura M; Hatake K; Komatsu N; Kajitani H; Miura Y
Lancet; 1994 Feb; 343(8893):361-2. PubMed ID: 7905175
[No Abstract] [Full Text] [Related]
19. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
Haanen C; Vermes I
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid in myelogenous leukaemia.
Gallagher RE; Wiernik PH
Lancet; 1991 Dec 21-28; 338(8782-8783):1603. PubMed ID: 1684016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
